Truist Securities Reiterates Buy on Option Care Health, Maintains $39 Price Target
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst David Macdonald reiterated a Buy rating on Option Care Health (NASDAQ:OPCH) and maintained a $39 price target.
June 27, 2023 | 1:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities analyst David Macdonald reiterated a Buy rating on Option Care Health (NASDAQ:OPCH) and maintained a $39 price target.
The reiteration of a Buy rating and maintenance of a $39 price target by Truist Securities analyst David Macdonald indicates a positive outlook for Option Care Health. This news is likely to have a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100